These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37072863)
1. Optimal statin use for prevention of sepsis in type 2 diabetes mellitus. Sun M; Tao Y; Chen WM; Wu SY; Zhang J Diabetol Metab Syndr; 2023 Apr; 15(1):75. PubMed ID: 37072863 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study. Yu JM; Chen WM; Shia BC; Wu SY Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535 [TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus. Yu JM; Chen WM; Shia BC; Wu SY Curr Atheroscler Rep; 2023 Sep; 25(9):619-628. PubMed ID: 37515725 [TBL] [Abstract][Full Text] [Related]
4. Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus. Yu JM; Chen WM; Chen M; Shia BC; Wu SY Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111264 [TBL] [Abstract][Full Text] [Related]
5. Protective Effects Against Dementia Undergo Different Statin Type, Intensity, and Cumulative Dose in Older Adult Type 2 Diabetes Mellitus Patients. Sun M; Chen WM; Wu SY; Zhang J J Am Med Dir Assoc; 2024 Mar; 25(3):470-479.e1. PubMed ID: 38128583 [TBL] [Abstract][Full Text] [Related]
6. Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients Yu JM; Chen WM; Shia BC; Wu SY Diab Vasc Dis Res; 2023; 20(6):14791641231214507. PubMed ID: 37933122 [TBL] [Abstract][Full Text] [Related]
7. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study. Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752 [TBL] [Abstract][Full Text] [Related]
8. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study. Na E; Cho S; Kim DJ; Choi J; Han E Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM. Wu SY; Chen WM; Chiang MF; Lo HC; Wu MS; Lee MC; Soong RS Liver Int; 2023 Oct; 43(10):2232-2244. PubMed ID: 37381761 [TBL] [Abstract][Full Text] [Related]
10. Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study. Liu JC; Hao WR; Hsu YP; Sung LC; Kao PF; Lin CF; Wu AT; Yuan KS; Wu SY Oncotarget; 2016 Oct; 7(40):65270-65283. PubMed ID: 27542242 [TBL] [Abstract][Full Text] [Related]
11. Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patients. Lin CY; Chang CL; Lin KC; Chen WM; Shia BC; Kuo PH; Wu SY Radiother Oncol; 2024 Feb; 191():110067. PubMed ID: 38142934 [TBL] [Abstract][Full Text] [Related]
12. Statins Dose-Dependently Exert Significant Chemopreventive Effects Against Various Cancers in Chronic Obstructive Pulmonary Disease Patients: A Population-Based Cohort Study. Chen CC; Hsu YP; Liu JC; Kao PF; Sung LC; Lin CF; Hao WR; Liu SH; Wu SY J Cancer; 2016; 7(13):1892-1900. PubMed ID: 27698930 [No Abstract] [Full Text] [Related]
13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
14. Statins and the risk of pancreatic cancer in Type 2 diabetic patients--A population-based cohort study. Chen MJ; Tsan YT; Liou JM; Lee YC; Wu MS; Chiu HM; Wang HP; Chen PC Int J Cancer; 2016 Feb; 138(3):594-603. PubMed ID: 26296262 [TBL] [Abstract][Full Text] [Related]
15. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis. Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433 [TBL] [Abstract][Full Text] [Related]
16. Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma. Talwar N; Musch DC; Stein JD JAMA Ophthalmol; 2017 Mar; 135(3):263-267. PubMed ID: 28114645 [TBL] [Abstract][Full Text] [Related]
17. Risk of incident diabetes among patients treated with statins: population based study. Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM BMJ; 2013 May; 346():f2610. PubMed ID: 23704171 [TBL] [Abstract][Full Text] [Related]
18. Statin Use and Mortality among Patients Hospitalized with Sepsis: A Retrospective Cohort Study within Southern California, 2008-2018. Liang B; Yang ST; Wei KK; Yu AS; Kim BJ; Gould MK; Sim JJ Crit Care Res Pract; 2022; 2022():7127531. PubMed ID: 35573912 [TBL] [Abstract][Full Text] [Related]
19. Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database. Lee J; Noh Y; Shin S; Lim HS; Park RW; Bae SK; Oh E; Kim GJ; Kim JH; Lee S Ther Clin Risk Manag; 2016; 12():1533-1543. PubMed ID: 27785041 [TBL] [Abstract][Full Text] [Related]
20. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk. Liu JC; Hsu YP; Wu SY PLoS One; 2016; 11(9):e0162588. PubMed ID: 27632175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]